Argus Research Keeps "Buy" Rating for Ashland, Lowers Price Target to $65

Argus Research maintains "Buy" rating on Ashland (ASH) but lowers price target to $65, a 7.14% decrease from $70. Analyst Alexandra Yates made the update. The average one-year price target for Ashland is $63.63, with an upside of 12.41% from the current price of $56.60. The average brokerage recommendation is 2.1, indicating "Outperform" status. GF Value estimates a fair value of $84.61 in one year, suggesting a 49.49% upside from the current price.

In the latest quarterly report, Argus Research has maintained its "Buy" rating on Ashland Inc. (ASH), but has revised its price target downward to $65, representing a 7.14% decrease from the previous target of $70. This update was made by Alexandra Yates, an analyst at Argus Research. The new price target reflects a cautious outlook on Ashland's current market conditions and future prospects [1].

The average one-year price target for Ashland, as per the latest analyst consensus, stands at $63.63, indicating an expected 12.41% upside from the current price of $56.60. This average target is slightly lower than the previous quarter's average, suggesting a more conservative view among analysts. The average brokerage recommendation remains at 2.1, indicating an "Outperform" status for the company [1].

Additionally, the GF Value model estimates a fair value of $84.61 for Ashland in one year, suggesting a potential 49.49% upside from the current price. This valuation indicates a significant appreciation in the stock's value if the company meets its projected performance targets [1].

Ashland Inc. operates as a global specialty materials company, serving a diverse range of industrial markets. The company's business model is organized into four segments: life sciences, personal care, specialty additives, and intermediates. Despite the recent downward revision in price targets, the company's strong financial fundamentals, including a robust net margin and a conservative debt-to-equity ratio, continue to provide a solid foundation for its operations [1].

In conclusion, while Argus Research has lowered its price target for Ashland, the company's "Buy" rating and the overall positive analyst consensus suggest that investors may still find value in the stock. The key for Ashland will be to continue delivering on its strategic initiatives and operational efficiency to justify the higher valuation targets.

References:

[1] https://www.benzinga.com/insights/analyst-ratings/25/08/47344556/breaking-down-ashland-4-analysts-share-their-views